Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00186_DB00427_nanopub.RATvnGA2wS1ViuxxMMfxGEZ2YRMIQMNmI3CvP5P-0qYJw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00186_DB00427 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00186_DB00427 label "DDI between Lorazepam and Triprolidine - The CNS depressants, Triprolidine and Lorazepam, may increase adverse/toxic effects due to additivity. Monitor for increased CNS depressant effects during concomitant therapy. [drugbank_resource:DB00186_DB00427]" assertion.
- drugbank_resource:DB00186_DB00427 identifier "drugbank_resource:DB00186_DB00427" assertion.
- drugbank_resource:DB00186_DB00427 title "DDI between Lorazepam and Triprolidine - The CNS depressants, Triprolidine and Lorazepam, may increase adverse/toxic effects due to additivity. Monitor for increased CNS depressant effects during concomitant therapy." assertion.
- drugbank:DB00186 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00186_DB00427 assertion.
- drugbank:DB00427 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00186_DB00427 assertion.